Australia: They would launch a synthetic vaccine for FA and LSD in August 2023

Published 2022년 9월 22일

Tridge summary

Australia is set to launch the world's first synthetic vaccine for foot-and-mouth disease (FMD) and contagious lumpy skin disease (LSD) in August 2023, thanks to a government investment of $6 million. The vaccine is crucial as current FMD vaccines cannot be used in Australia due to the live virus, risking the country's FMD-free status. The national government has also allocated an additional $65 million over the next two years to boost biosecurity and train technicians to combat these diseases. The first conference in New South Wales brought together 120 experts to discuss the threat of FMD and LSD, with concerns about climate change potentially aiding the spread of LSD in Australia.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

As indicated by the Australian portal ABC, the first synthetic vaccine in the world for foot-and-mouth disease and contagious lumpy skin disease (LSD) would arrive in August of next year thanks to a government investment of 6 million Australian dollars (almost $17.6 billion). The funding announcement was made at the first New South Wales (NSW) state biosecurity conference, which was attended by a range of industry experts who came together to discuss exotic diseases currently threatening Australian livestock. This year has presented unprecedented risks to growers and the industry, as local growers also faced varroa destructor (mite), Japanese encephalitis (affecting pigs, horses, and humans), and a variety of threats to vegetation. Current FMD vaccines cannot be used locally as they contain live virus, which means that any vaccinated animals would have to be euthanized for Australia to retain its FMD free status. Hence the interest in creating a synthetic vaccine. “We want to be ...
Source: MXContexto

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.